Quick Answer
Telomir Pharmaceuticals, Inc. reported Total Assets of $7.34 million for fiscal year 2025.
Telomir Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $7.34M | +454.5% |
| 2024 | $1.32M | -72.3% |
| 2023 | $4.77M | +9696.4% |
| 2022 | $48.7K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.40M | +610.4% | +792.2% |
| June 30, 2025 | $829.6K | -60.5% | +68.9% |
| March 31, 2025 | $491.2K | -86.0% | -62.9% |
| December 31, 2024 | $1.32M | -72.3% | +27.1% |
| September 30, 2024 | $1.04M | — | -50.4% |
| June 30, 2024 | $2.10M | — | -40.0% |
| March 31, 2024 | $3.50M | — | -26.6% |
| December 31, 2023 | $4.77M | — | — |
- Telomir Pharmaceuticals, Inc. showed an increase of +454.5% in Total Assets compared to the prior fiscal year.
- Over the 2022–2025 period, Telomir Pharmaceuticals, Inc.’s total assets has grown by 14965.4% (from $48.7 thousand to $7.34 million).
- The most recent figure is from Telomir Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: